Figure 9 — Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma

Research Paper|Volume 15, Issue 20|pp. 11389–11411

Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma

Back to articleFigure 9(9 of 11)

100%

Figure 9.Drug sensitivity analysis between the ICDRG score subtypes. (A–D) IPS evaluation shows the response to PD-1 and CTLA-4 of GC in ICDRG score subtypes. (E–P) Prediction of chemotherapy drug for GC in ICDRG score subgroups.